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Abstract
Background Avascular necrosis (AVN) is a significant and
potentially devastating complication following the treat-
ment of developmental dysplasia of the hip (DDH). The
reported rate of AVN following closed reduction for DDH
ranges from 4 to 60%, and the resultant influence on hip
development remains unclear.
Purpose A systematic review of the literature was under-
taken to evaluate the frequency of AVN after more than
5 years of follow-up in children that underwent closed
reduction at younger than 2-years of age for DDH.
Methods The search strategy was formulated with key-
concepts and keywords identified using the patient prob-
lem, intervention, comparison and outcome process. Sear-
ches were undertaken using Pubmed, Scopus and Web of
Science up to and including May, 2016 to identify potential
studies.
Results A total of seven papers met the a priori inclusion
and exclusion criteria of this review. The overall rate of
significant AVN in 441 patients (538 hips) was 10% at a
mean length of follow-up of 7.6 years (5–18.8) following
closed reduction. This finding can be used to inform the
feasibility of future intervention studies, and act as a
baseline for which surgeons to compare their results to a
‘standard’.
Keywords Developmental dysplasia of the hip 
Congenital hip dislocation  Closed reduction  Avascular
necrosis  Systematic review
Introduction
Closed reduction and spica casting is one of the most
commonly performed procedures for the treatment of
developmentally dislocated hips (DDH). Whilst the pro-
cedure may be considered ‘minimally invasive’ and com-
monplace, it is not without complications. The primary
complication of closed reduction is avascular necrosis
(AVN) of the femoral head that occurs due to diminished
blood supply to the femoral epiphysis that can cause dev-
astating clinical outcomes [1–7]. The aetiology of the AVN
in closed reduction is thought to be a positional vascular
occlusion in the spica cast, though the position-at-risk
varies by child, and determination of this position cannot
yet be routinely individualized. The ‘optimal position in
spica cast’ therefore relies on a best-fit approach; using the
safe-zone of Ramsey [8].
Reported frequency estimates of AVN following closed
reduction vary significantly between 4 and 60% [1–7].
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There is therefore a significant discrepancy in the literature,
with difficulty in interpreting the expected rate of AVN.
Whilst this variation may be a consequence of natural
variation due to the relatively small case numbers, it may
similarly be due to systemic differences such as case
selection, or surgical technique (i.e. cast position, duration
of treatment, tendon release). A clear understanding of the
expected AVN rate would empower surgeons to audit their
own practice against a ‘standard’, would provide feasibility
data for the measure of effect size in future intervention
studies, and may help to elicit if there are particular aspects
of the surgical intervention that may particularly heighten
the risk of AVN.
The purpose of this study was to systematically evaluate
the literature of children having underwent closed reduc-
tion under 2-years of age for DDH, to determine the fre-
quency of AVN after more than 5-years of follow-up.
Methods
Search strategy and criteria
The search was conducted within Pubmed, Scopus and
Web of Science up to and including May, 2016. The search
strategy was formulated with key-concepts and keywords
identified using the patient problem, intervention, com-
parison and outcome (PICO) process [9]. This identified
essential search-terms, which were exploded ensuring the
inclusion of relevant synonyms, alternative spellings and
related terms [10]. Individual search terms were combined
using Boolean technique to further refine the process. A
medical librarian was instrumental in helping to design the
search strategy.
Initial search keywords were broad and exploded terms,
to ensure full use of MeSH (Medical Subject Headings)
terms for maximum sensitivity. More specific terms and
limitations were subsequently introduced and combined to
refine the search [11] (Appendix 1).
For inclusion in the review, articles needed to be reports
of clinical studies of DDH treated by closed reduction in
human patients and a minimum series of ten hips. A
minimum of ten hips was selected to minimize the effect of
small sample bias in the overall analysis. The minimum
follow-up period was 5 years, therefore this must either
have been a feature of the study design, or the study must
have published sufficient data such that individual cases
with over 5 years of follow-up could be elicited. Shorter
follow-up periods were not considered, as later-onset AVN,
and more specifically type 2 AVN, that may not evident
until several years after surgery, could not be excluded.
Additionally, all studies had to report on AVN using a
recognized and previously published classification of
AVN. Exclusion criteria were made if studies reported on
closed reductions performed in children over 2 years of age
(unless individual patient data was available to include
such patients), and studies of children with teratologic hip
dislocations (i.e. fixed hip dislocations at birth that are
associated with congenital anomalies, other syndromes or
neuromuscular disease) as closed reduction is typically not
recommended in any of these subgroups. In addition, the
search was limited to studies in English.
Titles and abstracts were independently screened against
the inclusion criteria by two investigators with prior
experience of conducting systematic reviews (XX and
YY). If either investigator deemed that the title and abstract
fulfilled the inclusion criteria, then the full paper was
obtained. The same reviewers then screened the full papers
against the inclusion and exclusion criteria and the reason
that any paper failed to fulfill these criteria was noted. The
senior author (ZZ) resolved any disagreement between the
two reviewers. The reference lists of the included papers
and of any identified review articles were also assessed for
further relevant studies.
Data was extracted from those studies included inde-
pendently by the two investigators using a Genaidy Critical
Appraisal Instrument [12]. The detailed data from these
forms were entered into an excel spreadsheet to allow for an
assessment of heterogeneity and quality between studies.
Outcome reporting
Common AVN classifications systems have previously
been combined in the following manner [13]: Type 1 AVN
is identical in the Kalamchi and MacEwen, and Bucholz
and Ogden classifications, but does not result in long term
disease and has therefore not been considered clinically
significant AVN. Type 2 AVN is also identical in both
classifications and is thus considered together. Types 3 and
4 in each classification were recorded as clinically signif-
icant, and combined in a type 3 group. Salter classifica-
tion—in instances where the location of physeal damage is
reported, ‘no physeal damage’ is considered type 1, ‘lateral
physeal damage’ is considered type 2 and ‘central physeal
damage’ type 3 AVN. For the purposes of this study, only
types 2–4 AVN are considered clinically significant and
type 1 AVN is not included in the analysis.
Statistical analysis
The overall frequency of and type of AVN (types 2–4)
related to length of follow-up were evaluated across all
included studies. Mean age at closed reduction in months,
mean length of follow-up in years, percentages for gender
and AVN classification system used were identified for
each study.
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Results
The search identified 1492 possible titles and abstracts
(Fig. 1). Initial review of these excluded 1382 articles
and identified 28 review articles to further assess the
included references. This resulted in the retrieval of 82
full papers for confirmation of eligibility. Searching
references lists and conferring with experts did not add
any further articles. Review of the full papers excluded
an additional 72 articles leaving 7 articles (538 hips) for
analysis. Four of these articles met inclusion criteria for
all patients in their respective studies [14–17] and the
remaining three provided sufficient individual
patient data to be retrieved and included in the analysis
[18–20].
Data extraction
All seven studies were reports of case series and all but two
[14, 19] were formed retrospectively. All studies reported
outcomes of closed reduction for DDH including AVN.
Exclusion criteria for the studies included teratologic hips
and prior attempts at closed reduction. Most were con-
ducted at a single institution, one at two medical centers
[15] and one at four centers [16]. Summary details of each
of the studies are provided in Table 1.
Patient characteristics
Of the 441 patients (538 hips), 86.5% were female and
76.2% were unilateral in presentation. The mean age at
Duplicates n = 8
Other language n = 3
Not relevant n = 184
Other outcome/intervention  
n = 294
Other diagnoses  n = 893
n = 32 case study, commentary, 
review
n = 26 inadequate f/u or AVN 
classiication
n = 16 other approach/intervention
n= 1 same patients used in other 
included papers 
Fig. 1 Literature search results
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time of closed reduction was 9.6 months (range 1–21) with
a mean follow-up of 7.6 years (range 5–18.8) after closed
reduction.
Interventions
Previous treatment with a Pavlik harness was reported in
three of the studies [15, 17, 18] and pre-operative traction
was used at varying rates in all but one study [16]. The
closed reductions were performed either by a staff surgeon
or under their supervision. Soft tissue releases were not
routinely performed in all studies, but when completed,
adductor longus was the only one noted. Reported time in
spica ranged from 6 weeks [14] to 6 months [19]. Position
of immobilization also ranged from a combined 100 of
flexion, 20 of abduction [15] to combined flexion of 100–
110, 40–60 of abduction and no internal rotation [17].
None reported using abduction greater than 60.
Overall rate of AVN
Significant AVN occurred in 52 of the 538 hips included
(441 patients), which equates to an AVN rate of 10% for
hips with a minimum of 5-years of follow-up [mean
duration of follow-up of 7.7 years (range 5–18.8)].
Time
There was no apparent temporal relationship between AVN
rate, and year of publication (Fig. 2). This suggests that
there was no significant change in practice over the
inclusion period, which significantly influenced AVN rates.
Size of study
There was a marked change in the AVN rate seen
depending on the size of the study; which is largely a
feature of common cause variation, with larger studies
having more certainty, and therefore narrower confidence
intervals. This is demonstrated using a funnel plot in Fig. 3.
The funnel plot indicates that the target line for the pre-
dicted ‘normal’ rate of AVN (types 2–4) following closed
reduction is 10%. The control limits, drawn using three
standard deviations, demonstrate that much of the variation
within the published literature is explained by common
cause variation, as the results lie within the control limits.
One study fell significantly outside the control limits [18].
Discussion
This is the only review that has synthesized long-term
AVN outcomes following closed reduction for Develop-
mental Dysplasia of the Hip (DDH). This study has
demonstrated that the mean rate of AVN within the liter-
ature is 10% after 5-years follow-up after closed reduction,
amongst children treated before 2 years old. This result
offers a ‘target’ against which clinicians may compare their
results and offers a summary measure for use when pow-
ering intervention studies.















Bicimoglu et al. [16] 143 185 88.8 11.6 (3–18) 7.5 (5–13) K&M 5.4 (10/185)
Carney et al. [18] 32 35 77.1 8.2 (1–21) 8.75 (5.3–13.6) B&O 37.1 (13/35)
Cooke et al. [15] 42 48 92.9 10.2 (2–20.6) 11.1 (5–18.8) K&M 2.1 (1/48)
Danielsson [19] 65 67 89.4 10 (2–20) 11.7 (6.2–18.2) Salter
K&M
6 (4/67)
Forlin et al. [20] 28 33 89.3 13 (3–21) 7.3 (5.3–12.6) K&M 6 (2/33)
Khoshhal et al. [14] 85 124 69.4 7.3 (3–14) ‘‘Minimum 5 years’’—no
further details given.
K&M 10.5 (13/124)
Pospischill et al. [17] 46 46 83.3 4 (1.2–10.4) 6.3 (5.2–7.2) B&O 19.6 (9/46)









Fig. 2 Scatter plot illustrating the relationship between year of
publication and the rate of types 2–4 AVN
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The wide variations in the published results of AVN, is
likely to be largely a consequence of common cause (nat-
ural) variation [21]. Common cause variation cannot be
eliminated, and reflects the confidence or certainty within a
sample. As the sample size is increased, the certainty
increases, and the confidence interval narrows; hence a
funnel is formed. Data points occurring outside the funnel
are special cause variations, which indicate that an
extrinsic cause is influencing the outcomes seen. Special
cause variation may be due to differences in technique,
surgeon factors or systematic differences in the way that a
study is run. The result of one of the papers within this
review fell significantly outside the control limits, indi-
cating ‘special cause variation’ [18]. This may therefore
indicate that there was a fundamental difference in some
part of intervention offered to these participants within this
study, or could be a consequence of a bias in the study
design (i.e. cases with AVN may have been more readily
identified and recruited owing to more frequent follow-up
visits). Such special cause variations require further
investigation in order to identify and act upon the special
cause.
With increasing transparency within surgery, it is
important that surgeons are able to audit their results
against a gold standard by which they can benchmark.
Likewise, it is also important that they understand the
concept of natural variation, such that they are able to
consider their results within the context of the number of
procedures that they undertake; thereby ensuring that their
benchmarking is appropriate. Internationally, arthroplasty
surgeons are perhaps most used to this type of scrutiny, as
the volumes by which they undertake procedures suffi-
ciently narrows confidence intervals in order to readily
identify outliers and act accordingly. Whilst this may be
somewhat more difficult within paediatric orthopaedics,
efforts to increase transparency and audit results (by indi-
vidual or centre) should be encouraged.
There may be specific aspects of the intervention that
may have a bearing on outcome that cannot be well
ascertained given the nature of this review and the included
studies. Other previous studies, not included within this
review, have made observations, particularly regarding the
importance of the presence of the ossific nucleus prior to
closed reduction [22, 23], though it remains controversial
[24]. In addition, there may be adaptions within the sur-
gical technique, such as routine adductor tenotomy and
duration and position of immobilization in spica casting
that may minimize the complication of AVN. This sug-
gestion warrants that well designed prospective analysis of
potential predictive factors. In association with the Inter-
national Hip Dysplasia Institute (IHDI), there is an ongoing
multicentre nationwide trial within the UK that is seeking
to address the timing of the intervention (i.e. immediate vs.
delayed after the appearance of the ossific nucleus). The
results of this, and other similar trials, may have profound
effects for the way that we manage DDH [25].
A systematic review such as this, attempts to harmonize
the results of a number of studies, by strictly defining
inclusion/exclusion and intervention variables. Whilst this
is useful to gain a summary measure, flaws within indi-
vidual studies are difficult to overcome. These flaws are
particularly apparent for retrospective case series, whereby
the population was never clearly defined, case ascertain-
ment was unclear, potential confounders were not recorded
(i.e. position in spica) and the methodological clarity was
limited. The review was also limited by the analysis of only
literature written in English, and the paucity of studies that
have reported long-term follow-up. Nevertheless, the study
of rare outcomes is challenging in a prospective manner
[26], owing to the costs and infrastructure required to
identify and follow-up cases in a systematic manner,
therefore a pragmatic approach must be considered.
This review has enabled individual surgeons/centres to
benchmark themselves against the most robust studies of
outcome within the literature and has set a summary
measure against which future studies may compare
outcomes.
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Fig. 3 Funnel plot to illustrate the rate of types 2–4 AVN, according
to study sample size
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